Revolution Medicines
The Associate Director, US Field Analytics, Lung serves as a key analytics partner to the field organization and Commercial leadership, combining hands-on analytical capabilities with strategic thinking to improve field strategy and performance. This role involves leading analytics across segmentation, targeting, field performance measurement, and resource optimization while partnering with senior business leaders to translate business questions into actionable recommendations. The position requires proficiency in technical analytics tools and the ability to drive adoption of analytical solutions across cross-functional teams.
Headquarters
Redwood City, California, United States
Company Size
201-500 employees
Founded
2014
Revolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
Victory Capital Management Inc. Trims Stock Holdings in Revolution Medicines, Inc. $RVMD
13 hours ago
Revolution Medicines Trials, Funding Capacity And Insider Moves Shape Risk Outlook
5 days ago
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Revolution Medicines.
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
1 week ago
Senior Manager, Targeting
CSL
Director, Business Analytics, Oncology - Lung
Regeneron Pharmaceuticals
Associate Director, US Consumer Analytics
sanofi us
NAG Medical Operations & Analytics Manager
NIVEA Polska
Marketing Analytics Vice President - Card Data Analytics
JPMorganChase
Analytics & Insights Analyst
Catalina USA